hackettg

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has retrospectively adjusted the reimbursement prices of certain products dispensed in March 2025. Under the current price change mechanism, pharmacy owners would have to wait one (or in some cases two months) before any NHS list prices changes are applied to reimbursement of branded products. The delays in reimbursement prices catching [...]

The post Retrospective reimbursement price adjustments for March 2025 appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Brilique 90mg tablets (G Pharma Ltd) Drug alert number: EL(25)A/19 Date issued: 29 April 2025 Jubilant Pharmaceuticals BV has informed the Medicines and Health products Regulatory Agency (MHRA) that the outer carton (box) of the product batches mentioned in this notification are missing the medicines legal classification for a Prescription [...]

The post MHRA Class 4 Medicines Defect Notification: Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg Capsules, (Jubilant Pharmaceuticals NV) appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 May 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Budesonide 1mg/2ml nebuliser suspension unit dose ampoules Zentiva Pharma UK Ltd 20 unit [...]

The post 6 products re-classified as a special containers from May 2025 appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 May 2025. PART IIIA – Professional fees (pharmacy contractors) Contractors should note the English Pharmacy Contractor Single Activity Fee has changed from £1.27 to £1.46. This was [...]

The post Drug Tariff Watch – May 2025 appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Brilique 90mg tablets (G Pharma Ltd) Drug alert number: EL(25)A/18 Date issued: 24 April 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Brilique 90mg tablets (G Pharma Ltd) as G Pharma Ltd have informed the MHRA that there is [...]

The post MHRA Class 4 Medicines Defect Notification: Brilique 90mg tablets (G Pharma Ltd) appeared first on Community Pharmacy England.